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In patients with type 2 diabetes PDE5 inhibition (PDE5i) is associated with cardiac 
remodeling and reduced inflammatory cytokines1. In this study it was investigated if 
PDE5 inhibition prevents the development of cardiomyocyte hypertrophy associated 
with diabetes by modulation of specific subsets of circulating monocytes and tissue 
macrophages.
Leptin receptor–deficient db/db mice develop diabetes mellitus and cardiac 
hypertrophy. The db/db mice were treated with the PDE5 inhibitor sildenafil (SILD) 
for 8 weeks. In the hearts of SILD treated mice cardiomyocyte showed a reduced 
cross-sectional area compared to the cardiomyocyte of untreated mice. Expres-
sion of the hypertrophic marker β-myosin was up-regulated in db/db mice hearts 
and this increase was prevented by SILD treatment. Circulating pro-inflammatory 
CD11b+Gr-1+ myeloid cells and the CD11b+Gr-1− monocyte cells, were monitored 
during SILD treatment. CD11b+Gr-1+ cells were reduced after SILD treatment in db/
db mice compared with untreated ones. No significant changes of CD11b+Gr-1− cells 
were detected in both control and SILD treated animals. After tissue dissociation, car-
diac macrophages infiltration was characterized using specific markers such as F4/80 
and TIE2. F4/80+ macrophages in diabetic mice were 2-fold increased compared 
to untreated mice and they were reduced by SILD treatment. Proangiogenic TIE2 
expressing monocytes/macrophages (TEMs) percentage was highly increased in SILD 
treated db/db mice and correlated with an increase of vessel density, measured by 
the expression of the endothelial marker CD31. 
These data suggest that PDE5 inhibition attenuates inflammation in diabetic car-
diomyopathy reducing pro-inflammatory monocytes and in parallel increasing TEMs 
percentage and tissue vascularization.
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